Recital 1, Regulation (EU) 2018/781

In forcesince 29 May 2018

Regulation (EC) No 141/2000 was adopted to promote research in the field of rare diseases. It offers undertakings that develop orphan medicinal products the prospect of obtaining market exclusivity for a certain number of years.